CXCL8 and glioblastoma: Bender et al. [26] used a multiplex immunoassay platform and demonstrated at least double IL-10 levels in GBM patients compared to healthy controls, whereas the levels of other cytokines, i.e., IL-6, IL-8, and TNFα, did not differ between groups.